NIKKEI 225
27,819.33 -180.63 (-0.65%) HANG SENG
19,610.84 -392.60 (-1.96%) CRUDE OIL
91.45 -0.48 (-0.52%) GOLD FUTURES
1,807.30 -6.40 (-0.35%) DOW
33,309.51 +535.11 (+1.63%) BTC-GBP
19,575.42 +459.48 (+2.40%)
Orion Oyj (ORINY)
| Previous close | 20.00 |
| Open | 20.00 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 20.00 - 20.00 |
| 52-week range | 18.20 - 22.40 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 6.591B |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | 27.40 |
| EPS (TTM) | 0.73 |
| Earnings date | N/A |
| Forward dividend & yield | 0.83 (4.14%) |
| Ex-dividend date | 24 Mar 2022 |
| 1y target est | N/A |
- Globe Newswire
U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
ORION CORPORATION PRESS RELEASE 8 August 2022 at 9:30 EEST U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) Darolutamide now has indications in both non-metastatic castration-resistant prostate cancer (nmCRPC) for men at high risk of developing metastatic disease and metastatic hormone-sensitive prostate cancer (mHSPC).Approval under the FDA’s Real-Time Oncology Review (RTOR) pilot prog
- Globe Newswire
Orion Corporation: Managers’ transactions – Virve Laitinen
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 August 2022 at 11.15 EEST Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Virve
- Globe Newswire
Orion Group Half-Year Financial Report 1–6/2022
ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2022 15 JULY 2022 at 12:00 EEST Orion Group Half-Year Financial Report 1–6/2022 This is a summary or Orion’s Half-Year Financial Report 1–6/2022. The complete report is attached to this stock exchange release and is available at https://www.orion.fi/en/Orion-group/investors/financial-reviews-and-presentations/ Net sales totalled EUR 554 million (EUR 524 million in 2021). Operating profit was EUR 153 (146) million.Profit before taxes was EUR 155 (1
